EVALUATION OF RECEPTOR ACTIVATOR NUCLEAR KAPPA B LIGAND (RANKL) AND OSTEOPROTEGERIN (OPG) LEVELS IN PATIENTS WITH OSTEOPOROSIS AND BRONCHIECTASIS